AgeX Therapeutics(AGE) - 2023 Q4 - Annual Results

Exhibit 99.1 AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results ALAMEDA, Calif.—(Globe Newswire)—March 22, 2024—AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended December 31, 2023 and recent highlights. Recent Highlights ● Stockholders approved transactions for merger with Serina Therapeutics, Inc. ● Obtained $4. ...